hypoxia inducible factor, HIF-1α, and endothelial nitric oxide synthase, eNOS, expression). HIF-1α and eNOS expression) after two-hour reperfusion.CST-Post limits reperfusion damages and reverses the hypertension-induced increase of I/R susceptibility. Moreover, CST-Post triggers antiapoptotic and pro-angiogenetic factors suggesting that CST-Post can be used as an anti-maladaptive remodeling treatment
Background/Aims: Stem cell transplantation and gene therapies have been shown to attenuate myocardia...
In the present study, we hypothesized that postcon (postconditioning) confers cardioprotection in vi...
<div><p>In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment ...
hypoxia inducible factor, HIF-1α, and endothelial nitric oxide synthase, eNOS, expression). HIF-1α ...
BACKGROUND:In the presence of comorbidities the effectiveness of many cardioprotective strategies is...
Background: In the presence of comorbidities the effectiveness of many cardioprotective strategies i...
The Author(s) 2010. This article is published with open access at Springerlink.co
Catestatin (Cst) is a 21-amino acid peptide deriving from Chromogranin A. Cst exerts an overall prot...
Catestatin was discovered as a potent inhibitor of catecholamine secretion and plays important roles...
Copyright © 2013 Sverre E. Aune et al. This is an open access article distributed under the Creative...
Hypertension is associated with inflammation and excessive production of catecholamines. Hypertensiv...
Catestatin (CST) was first named in 1997 for its catecholamine-inhibitory activity. It was discovere...
IntroductionCardiac shock-wave therapy (CSWT) is a non-invasive regenerative treatment method based ...
In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment on myoca...
Objectives. Catestatin (CST) is a new endogenous neuropeptide with a potent catecholamine release-in...
Background/Aims: Stem cell transplantation and gene therapies have been shown to attenuate myocardia...
In the present study, we hypothesized that postcon (postconditioning) confers cardioprotection in vi...
<div><p>In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment ...
hypoxia inducible factor, HIF-1α, and endothelial nitric oxide synthase, eNOS, expression). HIF-1α ...
BACKGROUND:In the presence of comorbidities the effectiveness of many cardioprotective strategies is...
Background: In the presence of comorbidities the effectiveness of many cardioprotective strategies i...
The Author(s) 2010. This article is published with open access at Springerlink.co
Catestatin (Cst) is a 21-amino acid peptide deriving from Chromogranin A. Cst exerts an overall prot...
Catestatin was discovered as a potent inhibitor of catecholamine secretion and plays important roles...
Copyright © 2013 Sverre E. Aune et al. This is an open access article distributed under the Creative...
Hypertension is associated with inflammation and excessive production of catecholamines. Hypertensiv...
Catestatin (CST) was first named in 1997 for its catecholamine-inhibitory activity. It was discovere...
IntroductionCardiac shock-wave therapy (CSWT) is a non-invasive regenerative treatment method based ...
In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment on myoca...
Objectives. Catestatin (CST) is a new endogenous neuropeptide with a potent catecholamine release-in...
Background/Aims: Stem cell transplantation and gene therapies have been shown to attenuate myocardia...
In the present study, we hypothesized that postcon (postconditioning) confers cardioprotection in vi...
<div><p>In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment ...